The Asia Pacific production animal health market size was estimated at USD 10.04 billion in 2024 and is projected to reach USD 22.23 billion by 2033, growing at a CAGR of 9.23% from 2025 to 2033. The industry is driven by the region’s large and dense livestock population, rising protein consumption, and growing disease burden among production animals.
Countries like India and China collectively account for over one-third of the global cattle population, fueling consistent demand for veterinary pharmaceuticals, vaccines, and diagnostics. Increasing incidences of transboundary and zoonotic diseases such as foot-and-mouth disease, avian influenza, and African swine fever have increased the need for preventive healthcare and disease control measures. Additionally, growing government initiatives are driving market growth. For instance, in March 2025, the Union Cabinet approved a revised Livestock Health and Disease Control Programme (LHDCP) with a budget of INR 3,880 crore (USD 453 Mn) for 2024-25 and 2025-26. The revamped scheme consists of three core components: the National Animal Disease Control Programme (NADCP), Livestock Health & Disease Control (LH&DC), and the newly launched Pashu Aushadhi initiative. Key focus elements include mass vaccinations, deployment of mobile veterinary units, and distribution of affordable generic veterinary medicines through PM-Kisan Samriddhi Kendras (Centers) and cooperatives.
The market is undergoing a significant transformation, with India emerging as a key driver through cohesive policy actions, international collaborations, and regulatory reforms. In 2025, India launched a series of strategic initiatives to strengthen veterinary infrastructure and service delivery. Notably, the Indian Council of Agricultural Research (ICAR) conducted a large-scale Animal Health Camp targeting marginalized farming communities, offering veterinary services and awareness programs under the Scheduled Caste Sub-Plan (SCSP). This field-level outreach reflects a growing governmental commitment to inclusive animal healthcare.
Simultaneously, the Indian government introduced the USD 25 million ‘Animal Health Security Strengthening in India for Pandemic Preparedness and Response’ project, supported by the G20 Pandemic Fund, ADB, World Bank, and FAO. The initiative focuses on modernizing laboratory networks, improving surveillance systems, and upgrading digital disease reporting infrastructure, efforts expected to enhance preparedness for transboundary animal diseases across Asia.
Regulatory advancements also underscore India’s evolving animal health landscape. The removal of the outdated Target Animal Batch Safety Test (TABST) by the Indian Pharmacopoeia Commission in July 2024 marked a key alignment with global best practices in vaccine safety, reducing unnecessary animal testing. Further, a landmark partnership between the Department of Animal Husbandry and Dairying (DAHD) and UNDP introduced an AI-enabled digital platform to track vaccine stock, distribution, and cold chain management, while leveraging the Animal Vaccine Intelligence Network (AVIN) to support livestock insurance and immunization coverage. These coordinated actions not only improve animal health outcomes in India but also reflect broader regional trends in the Asia Pacific, where digitalization, public-private collaboration, and regulatory modernization are shaping a more resilient and sustainable production animal health ecosystem.
This product will be delivered within 2 business days.
Countries like India and China collectively account for over one-third of the global cattle population, fueling consistent demand for veterinary pharmaceuticals, vaccines, and diagnostics. Increasing incidences of transboundary and zoonotic diseases such as foot-and-mouth disease, avian influenza, and African swine fever have increased the need for preventive healthcare and disease control measures. Additionally, growing government initiatives are driving market growth. For instance, in March 2025, the Union Cabinet approved a revised Livestock Health and Disease Control Programme (LHDCP) with a budget of INR 3,880 crore (USD 453 Mn) for 2024-25 and 2025-26. The revamped scheme consists of three core components: the National Animal Disease Control Programme (NADCP), Livestock Health & Disease Control (LH&DC), and the newly launched Pashu Aushadhi initiative. Key focus elements include mass vaccinations, deployment of mobile veterinary units, and distribution of affordable generic veterinary medicines through PM-Kisan Samriddhi Kendras (Centers) and cooperatives.
The market is undergoing a significant transformation, with India emerging as a key driver through cohesive policy actions, international collaborations, and regulatory reforms. In 2025, India launched a series of strategic initiatives to strengthen veterinary infrastructure and service delivery. Notably, the Indian Council of Agricultural Research (ICAR) conducted a large-scale Animal Health Camp targeting marginalized farming communities, offering veterinary services and awareness programs under the Scheduled Caste Sub-Plan (SCSP). This field-level outreach reflects a growing governmental commitment to inclusive animal healthcare.
Simultaneously, the Indian government introduced the USD 25 million ‘Animal Health Security Strengthening in India for Pandemic Preparedness and Response’ project, supported by the G20 Pandemic Fund, ADB, World Bank, and FAO. The initiative focuses on modernizing laboratory networks, improving surveillance systems, and upgrading digital disease reporting infrastructure, efforts expected to enhance preparedness for transboundary animal diseases across Asia.
Regulatory advancements also underscore India’s evolving animal health landscape. The removal of the outdated Target Animal Batch Safety Test (TABST) by the Indian Pharmacopoeia Commission in July 2024 marked a key alignment with global best practices in vaccine safety, reducing unnecessary animal testing. Further, a landmark partnership between the Department of Animal Husbandry and Dairying (DAHD) and UNDP introduced an AI-enabled digital platform to track vaccine stock, distribution, and cold chain management, while leveraging the Animal Vaccine Intelligence Network (AVIN) to support livestock insurance and immunization coverage. These coordinated actions not only improve animal health outcomes in India but also reflect broader regional trends in the Asia Pacific, where digitalization, public-private collaboration, and regulatory modernization are shaping a more resilient and sustainable production animal health ecosystem.
Asia Pacific Production Animal Health Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Asia Pacific production animal health market report based on product, animal type, and country.Product Outlook (Revenue, USD Million, 2021 - 2033)
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
Animal Type Outlook (Revenue, USD Million, 2021- 2033)
- Poultry
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Antimicrobials
- Anti-infectives except Antimicrobial
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Anticoccidials
- Pre/Probiotics & Phytotherapeutics
- Performance enhancers (AGP)
- Other
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Swine
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Immunocastration
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Endectocides
- Other Parasiticides
- Anti-infectives
- Antimicrobials
- Anti-infectives except Antimicrobial
- Anti-inflammatory
- Analgesics
- Hormone Products
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Anticoccidials
- Performance enhancers (Probiotics + Phytogenics + Others Additives (β-adrenergic agonist)
- Other
- Others
- Veterinary TelehealthVeterinary Software
- Livestock Monitoring
- Cattle
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Artificial Insemination Products (Semen)
- Reproductive Disease Biologics
- Respiratory Disease Biologics
- Other Biologics except AI
- Pharmaceuticals
- Parasiticides
- Ectoparasiticides
- Endoparasiticides
- Endectocides
- Anti-infectives
- Antimicrobials
- Anti-infectives except Antimicrobial
- Anti-inflammatory
- Analgesics
- Hormone Products
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Oral MFAs
- Injectable MFAs
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Sheep & Goat
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Fish
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
Country Outlook (Revenue, USD Million, 2021 - 2033)
- Japan
- China
- India
- Indonesia
- Thailand
- Australia
- South Korea
- Philippines
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Asia Pacific Production Animal Health Market Variable Trends & Scope
Chapter 4. Asia Pacific Production Animal Health Market: Animal Type Estimates & Trend Analysis
List of Tables
List of Figures
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Zoetis
- IDEXX Laboratories, Inc.
- Merck & Co., Inc.
- Elanco
- Hester Biosciences Limited
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Virbac
- Dechra Pharmaceuticals Plc
